|Congratulations, Grant Recipients!|
GE Healthcare is pleased to announce the distinguished principal investigators who recently received research grants to investigate the use of LOGIQ™ E10 ultrasound technology in addressing liver health.
Liver disease affects millions of people worldwide, and ultrasound is a critical imaging tool in helping clinicians identify high-risk patients, monitor disease progression, and make informed decisions to optimize treatment efficacy and cost.
This research program—the latest in GE Healthcare’s commitment to advancing ultrasound innovation—will be led by esteemed ultrasound experts from around the globe:
John Eisenbrey, PhD
Thomas Jefferson University, Philadelphia, Pennsylvania, USA
AI Identification of Fatty Liver on Ultrasound: A Prospective Study
Jeong Min Lee, MD
Seoul National University Hospital, South Korea
B-Flow Imaging of Slow Blood Flow Signals in Residual or Recurrent HCC after TACE
Anthony Samir, MD, MPH
Massachusetts General Hospital, Boston, Massachusetts, USA
Improving Liver SWE in NAFLD With Conditionally Increased Acoustic Output
Jae Young Lee, MD, PhD
Seoul National University, South Korea
Investigation of HCC Surveillance and Liver Function in Kupffer Phase of Sonazoid with E10 Contrast
Pengfei Song, PhD
University of Illinois at Urbana-Champaign, Illinois, USA
Liver Cancer Therapy Response Evaluation with Super-Resolution Microvessel Imaging and SWE
Jens Ziegle, MSc
Otto-von-Guericke-University Magdeburg, Germany
Thermal Monitoring of Radiofrequency Ablation in Hepatic Tissue Using Autoregressive Modelling
GE Healthcare congratulates all of the grant recipients and extends appreciation to the many researchers who submitted proposals to advance the use of ultrasound in helping patients with liver disease live longer, healthier lives.